US FDA grants emergency use authorization to Regeneron COVID-19 antibody given to Trump
"The company said it expects to have does of REGEN-COV2 treatment ready for about 80,000 patients by the end of this month, about 200,000 patients by the first week of January and approximately 300,000 patients in total by the end of January.
The FDA said the antibodies are not authorized for patients who are hospitalized due to COVID-19 or require oxygen therapy due to COVID-19."
https://www.foxbusiness.com/markets/us-fda-grants-emergency-use-authorization-to-regeneron-covid-19-antibody-given-to-trump
No comments:
Post a Comment